MariMed Inc.

MRMD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $8.9M $7.3M $14.6M $9.7M $29.7M $3.0M $738.7K $4.1M
Accounts Receivable $9.1M $8.7M $7.2M $4.2M $1.7M $6.7M $1.7M $5.4M
Inventory $36.6M $33.5M $25.3M $19.5M $9.8M $6.8M $1.2M $90.5K
Total Current Assets $59.3M $53.5M $51.4M $44.1M $44.6M $21.0M $7.4M $15.7M
Property, Plant & Equipment $89.4M $94.2M $89.1M $71.6M $62.2M $45.6M $42.8M $34.1M
Goodwill $24.0M $15.8M $12.0M $8.1M $2.1M $2.1M — —
Intangible Assets (Excl. Goodwill) $17.2M $18.6M $17.0M $14.2M $162.0K $2.2M $2.4M $185.0K
Total Assets $202.6M $207.0M $196.1M $152.2M $123.2M $76.4M $61.6M $83.0M
Liabilities
Accounts Payable $14.6M $13.2M $9.0M $6.6M $5.1M $5.0M $4.7M $3.9M
Total Current Liabilities $59.1M $50.0M $30.9M $26.5M $27.2M $23.2M $36.7M $10.0M
Long-Term Debt $76.0M $78.2M — — — $36.7M $36.3M $15.0M
Total Liabilities $137.8M $129.4M $107.2M $57.2M $49.2M $53.6M $55.2M $21.2M
Stockholders' Equity
Retained Earnings $-127.9M $-113.4M $-100.0M $-83.9M $-97.4M $-104.6M $-106.8M $-25.6M
Total Stockholders' Equity $50.0M $58.5M $68.9M $57.3M $36.3M $8.1M $6.3M $61.8M
← Newer Page 1 of 2 Older →